Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease, Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/31/2019 |
| Start Date: | January 2013 |
| End Date: | December 2022 |
Peripheral Registry of Endovascular Clinical Outcomes
The PRIME Registry is a multi-center, observational study designed to evaluate immediate and
long-term outcomes (36 months) of endovascular revascularization in patients with critical
limb ischemia (CLI) and advanced peripheral artery disease (PAD).
long-term outcomes (36 months) of endovascular revascularization in patients with critical
limb ischemia (CLI) and advanced peripheral artery disease (PAD).
The Peripheral RegIstry of Endovascular Clinical OutcoMEs (PRIME Registry) represents the
collaborative effort among seven centers across the US with the goal of reaching 10 sites
globally. PRIME explores all aspects of advanced peripheral arterial disease (PAD) and
critical limb ischemia (CLI) care including the collection of comprehensive clinical,
diagnostic, procedural, and follow-up data for three years following an index endovascular
procedure. Data collection activities began in January of 2013 with the goal of collecting
data on 1500 subjects. Analysis of this multi-site registry will produce generalizable
findings that describe the clinical epidemiology and management practices of advanced PAD and
CLI patients.
collaborative effort among seven centers across the US with the goal of reaching 10 sites
globally. PRIME explores all aspects of advanced peripheral arterial disease (PAD) and
critical limb ischemia (CLI) care including the collection of comprehensive clinical,
diagnostic, procedural, and follow-up data for three years following an index endovascular
procedure. Data collection activities began in January of 2013 with the goal of collecting
data on 1500 subjects. Analysis of this multi-site registry will produce generalizable
findings that describe the clinical epidemiology and management practices of advanced PAD and
CLI patients.
Inclusion Criteria:
- Patients who are to receive or have received lower extremity endovascular intervention
- Rutherford III-VI Classification
- Ability to provide informed consent within 30 day prior to 60 days post index
endovascular intervention.
- Ability to follow up at enrollment site.
Exclusion Criteria:
- Inability or unwillingness to consent for participation in the registry.
We found this trial at
6
sites
Click here to add this to my saved trials
24 Sturtevant St
Orlando, Florida 32806
Orlando, Florida 32806
Principal Investigator: Farhan Khawaja, MD
Phone: 321-841-1505
Click here to add this to my saved trials
Raleigh, North Carolina 27607
Principal Investigator: George Adams, MD
Phone: 770-668-4972
Click here to add this to my saved trials
Springfield, Illinois 62701
Principal Investigator: Ashraf Al-Dadah, MD
Phone: 217-492-9100
Click here to add this to my saved trials
Springfield, Missouri 65807
Principal Investigator: John (Randy) Mullins, MD
Phone: 417-269-0599
Click here to add this to my saved trials
5900 Byron Center Ave SW
Wyoming, Michigan 49519
Wyoming, Michigan 49519
(616) 252-7200
Principal Investigator: Larry Diaz-Sandoval, MD
Phone: 616-252-8116
Metro Health Hospital Metro Health is an integrated healthcare system offering expert, award-winning care that
Click here to add this to my saved trials